You can be eating healthy, exercising, maintaining a reasonable weight, and doing all the things you've been told to do to stay healthy.

But what if your cardiovascular risk is changing behind the scenes, and nobody has bothered to tell you?

We spend so much time talking about hot flashes, belly fat, sleep problems, and brain fog during menopause. And yes, those things matter. But there's something much bigger happening in your body that deserves just as much attention.

Your cardiovascular system is changing as your estrogen levels decline.

And here's the part that really bothers me.

Heart disease remains the leading cause of death among women in the United States, yet cardiovascular health is still not a routine part of many menopause conversations.

We talk about mammograms. We talk about bone density. We talk about whether your hot flashes are keeping you up at night.

But how often does someone sit you down and explain what's happening to your arteries, cholesterol, blood vessels, and metabolic health as your estrogen levels decline?

Not nearly enough.

And considering that the changes can begin years before your final menstrual period, this is a conversation we should be having in our 40s, not waiting until we're 65.

So let's talk about what estrogen actually does for your cardiovascular system, why menopause changes your risk, which tests can give you a clearer picture, and what you can do about it.

Does Menopause Increase Your Risk of Heart Disease?

Yes. Cardiovascular risk increases during the menopause transition and after menopause. Declining estrogen, changes in cholesterol, increasing abdominal fat, insulin resistance, and vascular aging can all contribute. Aging also plays a role, but research suggests menopause itself is associated with additional cardiovascular changes.

In fact, the American Heart Association identifies the menopause transition as an important window for cardiovascular prevention.

And I think that's an important distinction.

Menopause isn't simply the moment your periods stop. It's a hormonal transition that can affect your blood vessels, metabolism, and body composition long before you officially become postmenopausal.

Research following women through menopause has found changes in LDL cholesterol, abdominal fat, and vascular health that cannot be explained by aging alone.

In other words, some of these changes are happening because your ovaries are changing how much estrogen they produce.

How Does Estrogen Protect Your Heart and Blood Vessels?

Estrogen does a lot more than regulate your menstrual cycle.

Estradiol, the primary estrogen during your reproductive years, interacts with receptors throughout your cardiovascular system.

That includes the cells lining your arteries, the smooth muscle surrounding your blood vessels, and tissues involved in cholesterol and glucose metabolism.

1. Estrogen helps your arteries relax

Your blood vessels are not rigid plumbing pipes. They're living tissues that constantly expand and contract to regulate blood flow.

Estradiol supports the production of nitric oxide, a molecule that helps blood vessels relax.

This process is called vasodilation.

When blood vessels relax appropriately, blood can flow more easily, and the cardiovascular system doesn't have to work as hard.

As estrogen declines, changes in endothelial function, the ability of your blood vessel lining to function properly, may contribute to increased arterial stiffness.

And stiffer arteries can contribute to rising blood pressure.

2. Estrogen influences cholesterol metabolism

Estradiol affects how the liver processes cholesterol and how lipoproteins circulate through the bloodstream.

As estrogen declines, LDL cholesterol often increases.

But LDL isn't the only piece of the puzzle.

We also need to consider the number of cholesterol-carrying particles, triglycerides, metabolic health, and inherited cardiovascular risk.

I'll explain why that matters in a moment.

3. Estrogen helps regulate glucose and insulin sensitivity

Estrogen also influences how your muscles, liver, and fat cells respond to insulin.

As estrogen declines, some women experience worsening insulin sensitivity, particularly when accompanied by increasing visceral fat and declining muscle mass.

This can contribute to higher blood glucose, increased triglycerides, and a greater risk of type 2 diabetes.

And diabetes is a major cardiovascular risk factor.

4. Estrogen influences inflammation and vascular function

Estradiol participates in several signaling pathways involved in inflammation, oxidative stress, and blood vessel function.

But estrogen isn't a simple on-off switch for inflammation.

Its effects depend on the tissue, hormonal environment, age, and other health factors.

The important takeaway is that declining estrogen can contribute to a collection of changes that make cardiovascular prevention especially important in midlife.

Estrogen is involved in heart health, but that doesn't mean replacing estrogen automatically prevents heart disease. Those are two different questions, and we'll get into that when we discuss HRT.

Why Does Belly Fat Increase During Menopause, and What Does It Have to Do With Your Heart?

One of the most frustrating changes women notice during perimenopause is that their body fat seems to migrate.

You may have spent most of your life carrying weight around your hips and thighs, only to suddenly find yourself developing a thicker waistline.

Same woman. Same eating habits. Sometimes even more exercise.

Different fat distribution.

What gives?

Estrogen plays an important role in where your body stores fat.

Before menopause, women generally tend to store more subcutaneous fat around the hips and thighs.

As estrogen declines, fat distribution often shifts toward the abdomen.

And some of that fat is visceral fat.

Unlike the fat sitting directly underneath your skin, visceral fat accumulates deeper in the abdominal cavity, surrounding internal organs.

Why does this matter?

Because visceral fat is metabolically active.

It releases inflammatory signaling molecules and free fatty acids that can contribute to insulin resistance, unfavorable cholesterol changes, and metabolic dysfunction.

This is one reason waist circumference can tell us something important about cardiovascular risk that the scale cannot.

You can have a relatively normal BMI and still carry excess visceral fat.

And you can be heavier on the scale while having good muscle mass and relatively favorable metabolic markers.

Your weight alone does not tell us how healthy your cardiovascular system is.

This is also why I talk so much about muscle during menopause.

Muscle helps dispose of glucose, supports insulin sensitivity, and plays an enormous role in metabolic health.

Losing muscle while gaining visceral fat is a combination we want to address early.

The 5 Cardiovascular Risk Factors That Deserve More Attention During Menopause

Menopause doesn't create one isolated cardiovascular problem.

It can influence several interconnected risk factors at the same time.

And this is where looking at the whole picture becomes important.

1. Rising LDL cholesterol and ApoB

You've probably been told to pay attention to your LDL and HDL cholesterol.

And yes, those numbers matter.

But they don't always tell the whole story.

LDL cholesterol measures the amount of cholesterol carried inside LDL particles.

Apolipoprotein B, or ApoB, helps estimate the number of potentially artery-clogging lipoprotein particles circulating in your bloodstream.

Why does particle number matter?

Imagine two highways.

One has a few large trucks carrying lots of cargo.

The other has hundreds of smaller trucks carrying the same total amount of cargo.

The amount of cargo may be similar, but the number of vehicles on the road is very different.

That's somewhat like the difference between LDL cholesterol and ApoB.

Two women can have similar LDL cholesterol levels but different numbers of atherogenic particles.

And those particles can enter the artery wall and contribute to plaque formation.

During menopause, LDL cholesterol commonly rises, making this an especially useful time to review your lipid results.

ApoB testing can be particularly helpful when someone has elevated triglycerides, diabetes, metabolic syndrome, or other factors that make standard cholesterol measurements less informative.

2. Increasing blood pressure

Blood pressure often rises with age, but menopause-related changes in vascular function and arterial stiffness can contribute.

The tricky part?

High blood pressure frequently has no obvious symptoms.

You can feel completely fine while your arteries are experiencing increased pressure.

That's why regular measurements matter, including home monitoring when appropriate.

3. Insulin resistance and rising blood sugar

Insulin resistance doesn't necessarily announce itself with dramatic symptoms.

Sometimes the earliest clues are increasing abdominal fat, higher triglycerides, elevated fasting glucose, or a rising A1c.

And you don't need to have diabetes for metabolic dysfunction to begin affecting cardiovascular risk.

Insulin resistance can contribute to inflammation, endothelial dysfunction, and changes in lipid metabolism.

This is one reason I don't believe we should separate hormone health from metabolic health.

They're connected.

4. Changes in inflammation

Inflammation plays a central role in atherosclerosis, the process through which plaque develops in artery walls.

A high-sensitivity C-reactive protein test, or hs-CRP, can sometimes provide additional information about cardiovascular risk.

But there's a catch.

CRP is not specific to cardiovascular disease.

It can rise because of an infection, injury, inflammatory condition, or other causes.

So an elevated result doesn't automatically mean you have heart disease.

It's one piece of information, not a diagnosis, and it isn't a necessary screening test for every woman.

5. Sleep problems, stress, and hot flashes

Here's something interesting.

Hot flashes and night sweats may tell us more than simply whether you're uncomfortable.

Research has found associations between frequent or severe vasomotor symptoms and less favorable cardiovascular risk profiles.

That does not mean hot flashes cause heart disease.

But it does suggest that menopause symptoms and cardiovascular health may share some underlying biological pathways.

Poor sleep also matters.

When you're sleeping four or five broken hours a night, your blood pressure, appetite regulation, glucose metabolism, and stress responses can all be affected.

And if you're waking up exhausted every morning, it's worth investigating why.

Sleep apnea, for example, becomes more common after menopause and is associated with hypertension and cardiovascular disease.

[INTERNAL LINK: menopause insomnia and hormone changes]

Which Heart Health Tests Should Women Consider During Menopause?

At a minimum, cardiovascular assessment during menopause should include blood pressure, cholesterol, blood glucose or A1c when indicated, smoking status, family history, and an overall cardiovascular risk assessment.Depending on your personal risk, additional tests such as ApoB, lipoprotein(a), or coronary artery calcium scoring may provide useful information.

This is where I think women can become much more proactive.

Instead of simply asking, "Is my cholesterol normal?" ask, "What does my overall cardiovascular risk look like?"

Because normal isn't always the same as low risk.

Test	What it tells you
Blood pressure	Whether pressure inside your arteries is elevated
Standard lipid panel	LDL, HDL, total cholesterol, and triglycerides
ApoB	Estimates the number of atherogenic lipoprotein particles
Lipoprotein(a), or Lp(a)	Identifies an important, largely inherited cardiovascular risk factor
Fasting glucose or HbA1c	Helps identify diabetes and abnormalities in blood glucose regulation
hs-CRP	May help refine cardiovascular risk assessment in selected women
Coronary artery calcium (CAC) scan	Detects calcified plaque in coronary arteries and can help clarify risk

Why lipoprotein(a) deserves special attention

Lp(a) is a cholesterol-carrying particle strongly influenced by genetics.

Unlike LDL cholesterol, which can change substantially with diet and medication, Lp(a) levels are largely inherited.

Elevated Lp(a) is associated with increased risk of atherosclerotic cardiovascular disease and aortic valve stenosis.

And here's the frustrating part.

You can eat beautifully, exercise regularly, and have a healthy body weight while still having elevated Lp(a).

The 2026 American Heart Association and American College of Cardiology dyslipidemia guideline recommends measuring Lp(a) at least once in adulthood.

For many women, this is a test they've never heard of.

What about coronary artery calcium scoring?

A coronary artery calcium scan is a specialized CT scan that looks for calcified plaque in the arteries supplying your heart.

A higher calcium score generally indicates a greater burden of coronary atherosclerosis.

A score of zero can be reassuring in many circumstances, but it doesn't completely rule out cardiovascular disease or noncalcified plaque.

And it isn't a test every woman needs.

It's particularly useful when your clinician is uncertain about your cardiovascular risk or whether cholesterol-lowering treatment is appropriate.

The 2026 dyslipidemia guideline supports selective CAC testing, including in women age 45 and older when results could meaningfully influence treatment decisions.

The point isn't to order every test available.

It's to use the right information to make better decisions.

Can You Have Heart Disease Even If Your Cholesterol Is Normal?

Yes. A normal cholesterol panel does not rule out coronary artery disease or guarantee a low cardiovascular risk.Blood pressure, diabetes, smoking, genetics, Lp(a), and existing arterial plaque all influence risk.

This is a misconception I really want women to understand.

Being thin doesn't automatically mean you're metabolically healthy.

Exercising doesn't guarantee your arteries are plaque-free.

And having a normal LDL cholesterol level doesn't eliminate the possibility of atherosclerosis.

Family history is especially important.

If a parent or sibling developed premature cardiovascular disease, generally before age 55 in men or 65 in women, that should be part of your risk assessment.

Your pregnancy history matters too.

Conditions such as preeclampsia and gestational diabetes can signal increased cardiovascular risk later in life.

So can premature menopause before age 40 and early menopause before age 45.

These are details that deserve a place in your medical history, not just your gynecology chart.

Does Hormone Replacement Therapy Reduce Heart Disease Risk?

Menopausal hormone therapy can improve certain cardiovascular and metabolic risk factors, particularly when initiated closer to menopause. However, hormone therapy is not currently recommended solely to prevent heart attacks, strokes, or cardiovascular disease.

This is where the conversation gets interesting.

And it's also where we need to stop lumping every type of hormone therapy together.

For years, women have heard conflicting messages about estrogen and heart disease.

First, estrogen was considered protective.

Then the Women's Health Initiative raised serious concerns about cardiovascular events, stroke, and blood clots with certain hormone therapy regimens.

Then additional research helped us understand that age, timing, formulation, and route of administration all matter.

So what's the current picture?

The timing of hormone therapy matters

Research suggests that the cardiovascular effects and risks of hormone therapy may differ depending on when treatment begins and what type of HRT you take transdermal vs oral estrogen has different risk factors.

This is often called the timing hypothesis.

For generally healthy women younger than 60 or within 10 years of menopause, the benefit-risk balance of systemic hormone therapy for bothersome menopausal symptoms is often more favorable than for women starting later.

But that doesn't mean starting HRT early guarantees protection against heart disease.

Nor does it mean every woman should be taking estrogen.

Your personal history, cardiovascular risk, and treatment goals matter.

Oral estrogen and transdermal estradiol are not the same

When you swallow oral estrogen, it travels through the digestive system and passes through the liver before reaching the systemic circulation.

This is called first-pass hepatic metabolism.

That liver exposure influences the production of certain clotting proteins, inflammatory markers, and triglyceride metabolism.

Transdermal estradiol, delivered through a patch, gel, or other skin preparation, largely bypasses that initial liver passage.

And that difference is clinically meaningful.

Research consistently finds a higher risk of venous thromboembolism, meaning blood clots in the veins, with oral estrogen than with transdermal estrogen.

The 2025 International Menopause Society recommendations favor transdermal estrogen for women with increased venous clotting risk who are otherwise appropriate candidates for hormone therapy.

For stroke, transdermal estrogen may also have a more favorable risk profile, particularly at lower doses, although the evidence is less definitive than it is for venous blood clots.

And when it comes to heart attacks, we still need to be careful.

A lower observed clotting risk does not prove that transdermal estradiol prevents coronary artery disease.

What about micronized progesterone?

Progesterone formulation matters too.

Micronized progesterone is chemically identical to the progesterone produced by the human body.

It has a different metabolic and vascular profile from some synthetic progestins.

Certain synthetic progestins may have less favorable effects on cardiovascular risk markers, while micronized progesterone is generally considered more metabolically neutral.

However, we do not have definitive randomized evidence showing that micronized progesterone prevents cardiovascular events.

And if you have a uterus and use systemic estrogen, adequate endometrial protection is essential.

What should women take away from the HRT conversation?

Hormone therapy can be an excellent treatment for appropriate women experiencing menopause symptoms, and it has established benefits for preventing bone loss.

Its effects on cardiovascular and metabolic health are important to understand.

But HRT should be part of an individualized menopause care plan, not treated as a replacement for cardiovascular screening, blood pressure management, or lipid-lowering therapy when those are indicated.

You can have beautifully managed menopausal symptoms and still have elevated ApoB, high blood pressure, or coronary plaque.

We need to look at both.

How to Lower Your Risk of Heart Disease During Menopause

The encouraging news is that cardiovascular risk is not determined by estrogen alone.

There are meaningful things you can do, starting now.

Build and maintain muscle

If you're not strength training yet, this is one of the best times to start.

Muscle helps regulate blood glucose, supports metabolic health, and makes it easier to maintain healthy body composition as you age.

Aim for resistance training at least twice per week, gradually increasing the challenge as your strength improves.

And don't forget aerobic exercise.

A general target is at least 150 minutes of moderate-intensity activity weekly, adjusted to your health and abilities.

Eat to support your arteries and metabolism

You don't need another extreme diet.

Focus on a dietary pattern that supports blood pressure, cholesterol, and blood glucose.

Think vegetables, fruit, beans, lentils, nuts, olive oil, high-fiber foods, and fish.

Adequate protein is also important for maintaining muscle.

Replacing saturated fats with unsaturated fats can help lower LDL cholesterol, and soluble fiber can support healthy cholesterol levels.

This doesn't have to be complicated.

Take sleep seriously

If you're waking up all night, snoring, experiencing night sweats, or struggling with persistent insomnia, don't just accept it as part of getting older.

Sleep disruption can affect blood pressure, insulin sensitivity, and overall cardiovascular health.

Treating menopausal symptoms and identifying conditions such as sleep apnea can be important parts of your care.

Know your numbers

You don't need to obsess over every biomarker.

But you should know your blood pressure, lipid levels, glucose status, and whether you have major inherited risk factors.

If your risk is elevated, lifestyle changes may not be enough on their own.

Medications for blood pressure, cholesterol, or diabetes can be important and evidence-based ways to prevent cardiovascular events.

Don't ignore smoking, alcohol, and chronic stress

Smoking is a major cardiovascular risk factor.

Alcohol can contribute to higher blood pressure, sleep disruption, and other health problems.

And chronic stress can affect cardiovascular health through both biological pathways and changes in behavior.

You cannot meditate away a high Lp(a), but managing stress, moving regularly, and improving sleep are still worthwhile.

What Are the Warning Signs of Heart Disease in Women?

Heart disease doesn't always look like the dramatic chest-clutching heart attack we see in movies.

Women can experience chest pressure or discomfort, but they may also have shortness of breath, nausea, unusual fatigue, lightheadedness, or pain in the back, jaw, neck, or arm.

Some women develop symptoms during physical activity that they mistakenly attribute to being out of shape, stressed, or menopausal.

And some cardiovascular disease progresses without obvious symptoms.

If you experience new, severe, or persistent chest discomfort, shortness of breath, fainting, or symptoms that could indicate a heart attack, seek emergency medical care immediately.

Don't assume it's anxiety, reflux, or menopause.

This is one area where I'd much rather you get checked and find out everything is fine than dismiss something important.

Frequently Asked Questions About Menopause and Heart Health

Does menopause cause high cholesterol?

Menopause can contribute to rising LDL cholesterol and changes in lipoprotein metabolism. However, genetics, diet, body composition, thyroid function, and aging also influence cholesterol levels. A lipid panel and overall cardiovascular risk assessment can help determine whether treatment is needed.

Can low estrogen cause heart palpitations?

Hormonal fluctuations during perimenopause can be associated with palpitations. However, palpitations can also result from thyroid disorders, anemia, medications, caffeine, or abnormal heart rhythms. New, frequent, or concerning palpitations should be evaluated rather than automatically blamed on hormones.

Is transdermal estrogen safer for the heart than oral estrogen?

Transdermal estradiol generally has a lower associated risk of venous blood clots than oral estrogen and may have a more favorable profile for certain cardiovascular risk factors. However, evidence does not establish that transdermal estrogen prevents heart attacks or is risk-free.

Can you have clogged arteries with normal cholesterol?

Yes. Normal cholesterol results do not rule out coronary artery plaque. Genetics, Lp(a), diabetes, smoking, blood pressure, and other factors influence atherosclerosis. In selected women, coronary artery calcium scoring can help clarify risk.

Should every menopausal woman have an ApoB test?

Not necessarily. ApoB can improve risk assessment, especially in women with diabetes, elevated triglycerides, metabolic syndrome, or discordance between LDL cholesterol and overall risk. It is useful to discuss with your clinician, but it is not required for everyone.

Does early menopause increase heart disease risk?

Yes. Women who experience menopause before age 45, particularly before age 40, have a higher average risk of cardiovascular disease later in life. Early menopause should be recognized as an important risk-enhancing factor when planning preventive care.

Can HRT reverse plaque in your arteries?

Hormone therapy has not been proven to reverse established coronary artery plaque or prevent cardiovascular events. Some studies suggest differences in atherosclerosis progression depending on treatment timing, but HRT is not a treatment for coronary artery disease.

The Bottom Line: Your Heart Deserves a Place in the Menopause Conversation

Here's what I want you to remember.

Menopause isn't just about hot flashes, sleep, or whether you can still fit into your favorite jeans.

It's a major transition in your cardiovascular and metabolic health.

And while we can't stop the aging process, we can identify risk factors earlier and make informed decisions that may change our long-term health.

That means looking beyond the scale.

Beyond whether your cholesterol was marked normal.

And beyond simply asking whether your hormone levels are high enough.

It means understanding your blood pressure, metabolic health, family history, lipid profile, and the role estrogen may be playing in your changing physiology.

The goal isn't to make women afraid of menopause. It's to make sure we're not missing an opportunity to protect their future health.

Because feeling good today matters.

But so does being healthy, active, and independent 20 or 30 years from now.

And I think women deserve a healthcare conversation that takes both seriously.

If you're navigating perimenopause or menopause and wondering whether your current treatment plan is addressing the bigger picture, explore the hormone education and individualized care options available through Midlife Solutions.

Research and References

1. El Khoudary SR, et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention. Circulation. 2020. https://pubmed.ncbi.nlm.nih.gov/33251828/

2. American Heart Association/American College of Cardiology. 2026 Guideline on the Management of Dyslipidemia. https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia

3. International Menopause Society. Recommendations and Key Messages on Women's Midlife Health and Menopause. 2025. https://doi.org/10.1080/13697137.2025.2585487

4. Endocrine Society. Treatment of the Symptoms of Menopause: Clinical Practice Guideline.https://support.endocrine.org/clinical-practice-guidelines/treatment-of-menopause

5. American Heart Association. Heart Disease Risk in Women Increases Leading Up to Menopause; Early Intervention Is Key. https://newsroom.heart.org/news/heart-disease-risk-in-women-increases-leading-up-to-menopause-early-intervention-is-key